IRONWOOD PHARMACEUTICALS INC Annual Weighted Average Number of Shares Outstanding, Diluted from 2010 to 2023

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Ironwood Pharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2010 to 2023.
  • Ironwood Pharmaceuticals Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 160M shares, a 14.3% decline year-over-year.
  • Ironwood Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 155M shares, a 16.6% decline from 2022.
  • Ironwood Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 186M shares, a 13.3% increase from 2021.
  • Ironwood Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 164M shares, a 2.34% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 155M -30.9M -16.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-16
2022 186M +21.9M +13.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-16
2021 164M +3.76M +2.34% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-16
2020 161M +4.63M +2.97% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-16
2019 156M +3.39M +2.22% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-18
2018 153M Jan 1, 2018 Dec 31, 2018 10-K 2021-02-17
2011 99.9M +10.2M +11.4% Jan 1, 2011 Dec 31, 2011 10-K 2012-02-29
2010 89.7M Jan 1, 2010 Dec 31, 2010 10-K 2012-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.